Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design
Description
Besides vaccines, the development of antiviral drugs targeting SARS-CoV-2 is critical for preventing future COVID outbreaks. The SARS-CoV-2 main protease (M^(pro)), a cysteine protease with essential functions in viral replication, has been validated